Product NDC: | 0469-3016 |
Proprietary Name: | Prograf |
Non Proprietary Name: | Tacrolimus |
Active Ingredient(s): | 5 mg/mL & nbsp; Tacrolimus |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0469-3016 |
Labeler Name: | Astellas Pharma US, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050709 |
Marketing Category: | NDA |
Start Marketing Date: | 19940408 |
Package NDC: | 0469-3016-01 |
Package Description: | 10 AMPULE in 1 BOX (0469-3016-01) > 1 mL in 1 AMPULE |
NDC Code | 0469-3016-01 |
Proprietary Name | Prograf |
Package Description | 10 AMPULE in 1 BOX (0469-3016-01) > 1 mL in 1 AMPULE |
Product NDC | 0469-3016 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Tacrolimus |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19940408 |
Marketing Category Name | NDA |
Labeler Name | Astellas Pharma US, Inc. |
Substance Name | TACROLIMUS |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |